← Back to Clinical Trials
Recruiting NCT07035795

NCT07035795 Cardiovascular Physiological Signal Recording Project

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07035795
Status Recruiting
Phase
Sponsor Chinese University of Hong Kong
Condition Cardiovascular Physiological Signal
Study Type OBSERVATIONAL
Enrollment 198 participants
Start Date 2025-05-14
Primary Completion 2029-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 198 participants in total. It began in 2025-05-14 with a primary completion date of 2029-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Vital sign monitoring is important for patients, especially those with underlying cardiovascular diseases. Traditional monitoring including SaO2, blood pressure, pulse, rhythm monitoring can be cumbersome, with wires and cuff attached to a patient. This can lead to reduced compliance, especially in uncooperative patients or young kids. The use of photoplethysmography (PPG) is simple and is widely used clinically to achieve continuous monitoring of SaO2, respiratory rate and pulse rate. PPG also contains important physiological signals that can correlate with blood pressure. Remote PPG (rPPG) with can be collected by cameras. This is being developed to achieve contactless monitoring. Theoretically, by analyzing video recording, the fluctuation of intensity of lights reflected from patients' body surface can be measured. Physiological parameters such as heart rate, SaO2, and blood pressure can then be calculated. However, because of environmental signal contamination, motion artefacts and other limitations, rPPG remains inaccurate for routine clinical use. To improve accuracy of PPG recordings, machine learning approach has been attempted. This study aims to gather physiological data from patients to train these models.

Eligibility Criteria

Inclusion Criteria: 1. Patients \> 18 years old 2. Has a known medical disease 3. Able to comply with recording of physiological signals Exclusion Criteria: 1\. Patients who are not able to provide informed consent

Contact & Investigator

Central Contact

Tsz Kin Mark Tam

✉ marktam@cuhk.edu.hk

📞 852 35051750

Frequently Asked Questions

Who can join the NCT07035795 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Physiological Signal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07035795 currently recruiting?

Yes, NCT07035795 is actively recruiting participants. Contact the research team at marktam@cuhk.edu.hk for enrollment information.

Where is the NCT07035795 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT07035795 clinical trial?

NCT07035795 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 198 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology